drugset / Trial / NCT00774761

A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease

NCT00774761

Phase 2 Completed 97 enrolled Dey
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the systemic exposure and pharmacodynamics of two doses of nebulized fluticasone/formoterol combination as compared to the monocomponents.

Timeline

Start
2008-11
Primary completion
2009-04
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone propionate Other / unclassified Inhaled
Comparator Formoterol Other / unclassified Inhaled